姜黄素及其类似物抑制CCl4诱导大鼠肝纤维化的作用及机制研究(4)
[13] Ge MX，Liu HT，Zhang N，et al. Costunolide represses hepatic fibrosis through WWP2-mediated Notch3 degradation [J]. Br J Pharmacol，2019，177(6)：1453.
[14] Li L，Li H，Zhang Z，et al. Recombinant truncated TGF-β receptor Ⅱ attenuates carbon tetrachloride-induced epithelial-mesenchymal transition and liver fibrosis in rats [J]. Mol Med Rep，2018，17(1)：315-321.
[15] Han F，Shu J，Wang S，et al. Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro [J]. Stem Cells Int，2019，2019：9019648.
[16] Gertz HJ，Kiefer M. Review about Ginkgo biloba special extract EGb 761(Ginkgo)[J]. Curr Pharm Des，2004，10(3)：261-264.
[17] Ezhilarasan D，Sokal E，Najimi M. Hepatic fibrosis：It is time to go with hepatic stellate cell-specific therapeutic targets [J]. Hepatobiliary Pancreat Dis Int，2018，17(3)：192-197.
[18] Hellerbrand C. Hepatic stellate cells—the pericytes in the liver [J]. Pflugers Arch，2013，465(6)：775-778.
[19] Xu F，Liu C，Zhou D，et al. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis [J]. J Histochem Cytochem，2016，64(3)：157-167.
[20] Hernández-Aquino E，Muriel P. Beneficial effects of naringenin in liver diseases：Molecular mechanisms [J]. World J Gastroenterol，2018，24(16)：1679-1707.
(收稿日期：2019-08-28 本文編辑：王晓晔), 百拇医药(王子恺 毛泳彬 孔力)
[14] Li L，Li H，Zhang Z，et al. Recombinant truncated TGF-β receptor Ⅱ attenuates carbon tetrachloride-induced epithelial-mesenchymal transition and liver fibrosis in rats [J]. Mol Med Rep，2018，17(1)：315-321.
[15] Han F，Shu J，Wang S，et al. Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro [J]. Stem Cells Int，2019，2019：9019648.
[16] Gertz HJ，Kiefer M. Review about Ginkgo biloba special extract EGb 761(Ginkgo)[J]. Curr Pharm Des，2004，10(3)：261-264.
[17] Ezhilarasan D，Sokal E，Najimi M. Hepatic fibrosis：It is time to go with hepatic stellate cell-specific therapeutic targets [J]. Hepatobiliary Pancreat Dis Int，2018，17(3)：192-197.
[18] Hellerbrand C. Hepatic stellate cells—the pericytes in the liver [J]. Pflugers Arch，2013，465(6)：775-778.
[19] Xu F，Liu C，Zhou D，et al. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis [J]. J Histochem Cytochem，2016，64(3)：157-167.
[20] Hernández-Aquino E，Muriel P. Beneficial effects of naringenin in liver diseases：Molecular mechanisms [J]. World J Gastroenterol，2018，24(16)：1679-1707.
(收稿日期：2019-08-28 本文編辑：王晓晔), 百拇医药(王子恺 毛泳彬 孔力)